Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| B05AA01 | HUMAN ALBUMIN "OCTAPHARMA" 20% | BioHuman | Albumin human - 20% | 20% | Injectable solution | 4863366.0075 |
| B05AA01 | HUMAN ALBUMIN 20% SOLUTION | BioHuman | Albumin human - 20% | 20% | Injectable solution | 4343342.868865 |
| B05AA01 | HUMAN ALBUMIN BEHRING 20%, LOW SALT | BioHuman | Albumin human - 20% | 20% | Injectable solution | 4343342.868865 |
| B05AA01 | PLASBUMIN-20 ALBUMIN (HUMAN) | BioHuman | Albumin human - 20% | 20% | Injectable solution | 3641813.175 |
| B05AA01 | UMAN ALBUMIN | BioHuman | Albumin human - 20g/100ml | 10g/50ml | Injectable solution | 3598810.215 |
| B05AA01 | VIALEBEX | BioHuman | Albumin human - 200g/L | 200g/L | Injectable solution | 3417391.4775 |
| B05 | 20 MEQ POTASSIUM OF 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP | B | Dextrose, H2O - 5%, Sodium chloride - 0.45%, Potassium chloride - 20meq | Injectable solution | 229958.5792 | |
| B05 | 20 MEQ POTASSIUM OF 0.9% SODIUM CHLORIDE INJECTION USP | B | Sodium chloride - 0.9%, Potassium chloride - 20meq | Injectable solution | 278101.56 | |
| B05 | 20 MEQ POTASSIUM OF 0.9% SODIUM CHLORIDE INJECTION USP | B | Sodium chloride - 0.9%, Potassium chloride - 20mEq | Injectable solution | 229958.5792 | |
| B05 | SOLUFLEX POTASSIUM CHLORIDE 40meq/l SODIUM CHLORIDE 0.9% INJECTION USP | G | Sodium chloride - 0.9%, Potassium chloride - 40meq/l | Injectable solution | 293040.9 | |
| B05 | SOLUFLEX POTASSIUM CHLORIDE 20meq/l SODIUM CHLORIDE 0.9% INJECTION USP | G | Sodium chloride - 0.9%, Potassium chloride - 20meq/l | Injectable solution | 232134.36 | |
| B03XA06 | REBLOZYL | BioTech | Luspatarcept - 25mg | 25mg | Injectable powder for solution | 125960784.42938 |
| B03XA06 | REBLOZYL | BioTech | Luspatercept - 75mg | 75mg | Injectable powder for solution | 377881317.80109 |
| B03XA01 | HEMAX | BioTech | Erythropoietin recombinant human (Epoetin alfa) - 10,000IU | 10,000IU | Injectable freeze dried substance+diluent | |
| B03XA01 | HEMAX | BioTech | Erythropoietin recombinant human (Epoetin alfa) - 40,000IU | 40,000IU | Injectable freeze dried powder + diluent | |
| B03XA01 | EPOMAX | BioTech | Erythropoietin recombinant human (Epoetin alfa) - 4000UI/ml | 4000UI/ml | Injectable solution |
Download the new version of the Ministry of Public Health application and discover new features providing reliable health information
and advanced digital services.
The new version allows you to scan medicine barcodes to verify whether the medication is officially registered with the Ministry of Public Health and distributed through approved official channels, contributing to enhanced patient safety and reducing counterfeit and illegal medicines. In addition to other healthcare services, including:
- Tracking medication records on MediTrack
- Locating the nearest healthcare facility
- Accessing information and statistics on nurseries
- Following the latest health news and updates
The Ministry encourages citizens to rely exclusively on the official application as a trusted source for accurate and reliable health information.
